Emcure Pharmaceuticals Ltd., has signed a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, one of the leading renewable power producers in India. This partnership will provide Emcure and its subsidiary, Gennova Biopharmaceuticals, with around 36 million units of clean, renewable energy annually for their Pune plants. This initiative will cover about 67% of their power needs and reduce CO2 emissions by 29,765.71 metric tons per year.
Emcure and Gennova have also signed a Shareholders Agreement to acquire a stake in Sunsure Solarpark Twelve Private Limited for solar power purchase under a group captive scheme. Sunsure Energy will supply this power from its 150 MWp DC solar plant in Solapur, Maharashtra.
Sunil Mehta, Whole-time Director of Emcure Pharmaceuticals Ltd., stated: “Our partnership with Sunsure Energy is a step towards reducing our carbon footprint by using renewable energy. Emcure is proud to lead the adoption of solar power in the pharmaceutical industry in India.”
Shashank Sharma, Founder and CEO of Sunsure Energy, added: “We are excited to partner with Emcure Pharmaceuticals. This PPA shows our commitment to helping leading corporations in the pharmaceutical sector transition to renewable energy.”
Emcure Pharmaceuticals is dedicated to environmental sustainability, using energy-efficient equipment, advanced waste management, and rainwater harvesting in its operations. Their 13 manufacturing plants have Zero Liquid Discharge systems and Effluent Treatment Plants, ensuring all waste is treated. These efforts reflect Emcure’s commitment to protecting the environment and promoting sustainable development.
